Carol Sharp
Women's Health · Sturgis, MINPI 1275534570
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 232 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$664
- AbbVie$660
- Amgen$335
- Pfizer$275
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$252
- Astellas Pharma US Inc$246
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,02896%
- Education$1764%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $664 |
| AbbVie(2 entities) | 39 | $660 |
| Amgen | 19 | $335 |
| Pfizer | 13 | $275 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $252 |
| Astellas Pharma US Inc | 6 | $246 |
| AstraZeneca | 13 | $215 |
| Lilly USA, LLC | 12 | $206 |
| Axsome Therapeutics, Inc. | 7 | $183 |
| Bayer | 9 | $138 |
| GSK | 9 | $135 |
| Vanda Pharmaceuticals Inc. | 5 | $126 |
| Boehringer Ingelheim | 5 | $89 |
| Merck | 5 | $83 |
| Corcept Therapeutics | 4 | $71 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $63 |
| Neurocrine Biosciences, Inc. | 3 | $63 |
| Idorsia Pharmaceuticals US Inc | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Madrigal Pharmaceuticals | 2 | $42 |
| Amarin Pharma, Inc. | 2 | $38 |
| Myriad Women's Health, Inc. | 1 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $33 |
| Upsher-smith Laboratories LLC | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Novartis | 1 | $15 |
| Insulet Corporation | 1 | $14 |
| Corium, LLC | 1 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $12 |
How this compares
$4,204 in reported general payments places this provider in the 95th percentile of 91 women's health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $463 |
| Clobetasol Propionate | 11 | $375 |
| Levothyroxine Sodium | 31 | $237 |
| Omeprazole | 19 | $197 |
| Atorvastatin Calcium | 19 | $72 |
| Hydroxyzine Hcl | 22 | $51 |
| Sertraline Hcl | 23 | $43 |
| Lisinopril | 11 | $36 |
| Meloxicam | 14 | $28 |
Paid to pharmacies, not to this prescriber.
Other women's health in Sturgis
- Nicole SoveyHartland$8K
- Diane WilliamsKalamazoo$4K
- Kimberly Texley-QuiggGrand Rapids$3K
- Bethany BondyTrenton$3K
- Emily ParkerGrand Rapids$3K
- Stephanie BreiningFarmington Hills$2K
- Jennifer AnnettaRoyal Oak$2K
- Cynthia KrauseMuskegon$2K
- Sarah PattersonRiverview$2K
- Alice JohnsonDetroit$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.